Conclusions This systematic review demonstrates that body weight is an important predictor of variation in circulating 25OHD in cohorts on vitamin D supplements .
Our model provides an estimate of the daily vitamin D dose that is necessary for achieving adequate circulating 25OHD levels in vitamin D-insufficient or vitamin D-deficient individuals/cohorts with different body weights and ages
Purpose There is considerable variation in incremental circulating 25-hydroxyvitamin D ( 25OHD ) levels on vitamin D supplements , even when similar age groups and identical vitamin D doses are compared .
We therefore aim ed to investigate the importance of body weight for the dose – response relation in circulating 25OHD .
Dose-Dependent Short-Term Effects of Single High Doses of Oral Vitamin D3 on Bone Turnover Markers
We investigated the short-term effects on bone turnover markers of high doses of vitamin D3 in order to identify what initial therapeutic dose can be safely administered in vitamin D-deficient subjects . Thirty-seven elderly subjects [ mean age 75 ± 3 ( SD ) years ] were consecutively r and omized to the administration of a single oral bolus of 600000 , 300000 , or 100000 IU vitamin D3 . Blood sample s were taken at baseline and 1 , 3 , 7 , 14 , 30 , 60 , and 90 days after vitamin D3 administration . Twenty-four subjects served as controls . No relevant changes in bone turnover markers [ C-terminal telopeptides of type I collagen ( sCTX ) and bone-specific alkaline phosphatase ( BAP ) ] were observed in the controls . In treated patients a dose-dependent effect on sCTX was observed . With the administration of 600,000 IU vitamin D3 a significant increase of sCTX was observed already at day 1 , and it was sustained for 2 months . The changes in sCTX with smaller doses were considerably lower and reached statistical significance only within the first 3 days with the 300,000 IU dose . BAP remained unchanged in patients given 300,000 and 600,000 IU vitamin D3 , while it significantly rose by 15–23 % throughout the observation period in patients given 100,000 IU . Our results indicate that the use of a vitamin D bolus exceeding 100,000 IU may be associated with acute increases of sCTX
Conclusions This systematic review demonstrates that body weight is an important predictor of variation in circulating 25OHD in cohorts on vitamin D supplements .
Our model provides an estimate of the daily vitamin D dose that is necessary for achieving adequate circulating 25OHD levels in vitamin D-insufficient or vitamin D-deficient individuals/cohorts with different body weights and ages
Purpose There is considerable variation in incremental circulating 25-hydroxyvitamin D ( 25OHD ) levels on vitamin D supplements , even when similar age groups and identical vitamin D doses are compared .
We therefore aim ed to investigate the importance of body weight for the dose – response relation in circulating 25OHD .